| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |